Literature DB >> 11014473

Immunodeficiency in alpha-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytes.

D Malm1, D S Halvorsen, L Tranebjaerg, H Sjursen.   

Abstract

UNLABELLED: Patients with the autosomal recessive lysosomal storage disease alpha-mannosidosis suffer from recurrent infections. To study the mechanisms of this immunodeficiency, six patients were matched against six healthy controls and their humoral and cellular immunocompetence investigated. No differences in the number of circulating leucocytes including B-cells, levels of immunoglobulin main classes, nor IgG subclasses were observed. However, post-immunisation serum levels of specific antibodies against poliovirus, diphtheria toxin and tetanus toxin were significantly reduced. In patients, the density of the complement-binding receptor CD11b and the Fc-receptor CD16 was significantly enhanced on monocytes and polymorphonuclear neutrophils (PMN) and the number of phagocytosing PMN was significantly increased in the presence of pooled human serum. This was not observed in the presence of autologous serum, indicating altered opsonic properties. Also in normal PMN, phagocytosis was inhibited by a factor in the serum from the patients. Despite maintained oxidative burst, patient PMN demonstrated insufficient intracellular bacterial killing.
CONCLUSION: Our data indicate that patients with alpha-mannosidosis have an immunodeficiency at both the humoral and cellular level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014473     DOI: 10.1007/s004310000545

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  The natural course and complications of alpha-mannosidosis--a retrospective and descriptive study.

Authors:  Dag Malm; Hilde Monica Frostad Riise Stensland; Øyvind Edvardsen; Øivind Nilssen
Journal:  J Inherit Metab Dis       Date:  2013-06-06       Impact factor: 4.982

2.  Destructive joint disease in alpha-mannosidosis. A case report and review of the literature.

Authors:  A H Gerards; W P C A Winia; J Westerga; B A C Dijkmans; R M van Soesbergen
Journal:  Clin Rheumatol       Date:  2003-11-13       Impact factor: 2.980

3.  Mannose 6 phosphorylation of lysosomal enzymes controls B cell functions.

Authors:  Takanobu Otomo; Michaela Schweizer; Katrin Kollmann; Valéa Schumacher; Nicole Muschol; Eva Tolosa; Hans-Willi Mittrücker; Thomas Braulke
Journal:  J Cell Biol       Date:  2015-01-19       Impact factor: 10.539

4.  Long-term outcome of patients with alpha-mannosidosis - A single center study.

Authors:  Patryk Lipiński; Agnieszka Różdżyńska-Świątkowska; Katarzyna Iwanicka-Pronicka; Barbara Perkowska; Paulina Pokora; Anna Tylki-Szymańska
Journal:  Mol Genet Metab Rep       Date:  2021-12-09

Review 5.  Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature.

Authors:  Julia B Hennermann; Eva M Raebel; Francesca Donà; Marie-Line Jacquemont; Graziella Cefalo; Andrea Ballabeni; Dag Malm
Journal:  Orphanet J Rare Dis       Date:  2022-07-23       Impact factor: 4.303

Review 6.  Alpha-mannosidosis.

Authors:  Dag Malm; Øivind Nilssen
Journal:  Orphanet J Rare Dis       Date:  2008-07-23       Impact factor: 4.123

7.  Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.

Authors:  Allan M Lund; Line Borgwardt; Federica Cattaneo; Diego Ardigò; Silvia Geraci; Mercedes Gil-Campos; Linda De Meirleir; Cécile Laroche; Philippe Dolhem; Duncan Cole; Anna Tylki-Szymanska; Monica Lopez-Rodriguez; Encarna Guillén-Navarro; Christine I Dali; Bénédicte Héron; Jens Fogh; Nicole Muschol; Dawn Phillips; J M Hannerieke Van den Hout; Simon A Jones; Yasmina Amraoui; Paul Harmatz; Nathalie Guffon
Journal:  J Inherit Metab Dis       Date:  2018-05-03       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.